Why the study?
The rising prevalence of HFpEF underscores the importance of epicardial adipose tissue, prompting investigation into the association of CMR-quantified EAT volume with left ventricular function and prognosis.
Does CMR-quantified epicardial adipose tissue (EAT) volume predict heart failure readmission or all-cause death in patients with HFpEF and high-risk individuals?
Cohort (n=244)
Does CMR-quantified epicardial adipose tissue (EAT) volume predict heart failure readmission or all-cause death in patients with HFpEF and high-risk individuals?
Answers are grounded in this paper and cite their sources.
CMR-quantified epicardial adipose tissue volume is strongly associated with HFpEF severity and may serve as a prognostic imaging biomarker for adverse outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Heart failure with preserved ejection fraction (HFpEF) (n=244). Epicardial adipose tissue (EAT) volume vs. Healthy controls and high-risk individuals was evaluated on Heart failure readmission or all-cause death.
Synapse has enriched 10 related papers. Consider them for comparative context: